rs766237791
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_003072.5(SMARCA4):c.2050G>A(p.Val684Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000123 in 1,461,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2050G>A | p.Val684Met | missense_variant | Exon 14 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.2050G>A | p.Val684Met | missense_variant | Exon 14 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.2050G>A | p.Val684Met | missense_variant | Exon 14 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.2050G>A | p.Val684Met | missense_variant | Exon 15 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.2050G>A | p.Val684Met | missense_variant | Exon 14 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.2050G>A | p.Val684Met | missense_variant | Exon 14 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.2050G>A | p.Val684Met | missense_variant | Exon 15 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.1462G>A | p.Val488Met | missense_variant | Exon 11 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.694G>A | p.Val232Met | missense_variant | Exon 7 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.775G>A | p.Val259Met | missense_variant | Exon 7 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.535G>A | p.Val179Met | missense_variant | Exon 6 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.403G>A | p.Val135Met | missense_variant | Exon 5 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251196Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135778
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461436Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727020
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:2
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 684 of the SMARCA4 protein (p.Val684Met). This variant is present in population databases (rs766237791, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 470276). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Intellectual disability, autosomal dominant 16 Uncertain:1
- -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at